Screening genes associated with elevated neutrophil‑to‑lymphocyte ratio in chronic heart failure

Wan,Guoxing; Ji,Lihua; Xia,Wenbin; Cheng,Lan; Zhang,Yonggang

doi:10.3892/mmr.2018.9132

Screening genes associated with elevated neutrophil‑to‑lymphocyte ratio in chronic heart failure

Authors:
- Guoxing Wan
- Lihua Ji
- Wenbin Xia
- Lan Cheng
- Yonggang Zhang
View Affiliations

Affiliations: Department of Cardiology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, P.R. China
Published online on: June 5, 2018 https://doi.org/10.3892/mmr.2018.9132
Pages: 1415-1422
Copyright: © Wan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neutrophil‑to‑lymphocyte ratio (NLR) is commonly considered a useful prognostic index for many cardiovascular diseases; however, it has limited sensitivity and specificity. Factors associated with elevated NLR may aid in the prediction of prognosis with heart failure (HF) in combination with NLR. The present study sought to identify decisive factors associated with NLR in HF patients and investigate their association with elevated NLR. The gene expression profile for blood samples from 197 individuals with chronic heart failure (CHF), with corresponding hematological parameters and clinical data were obtained from the public database, GSE77343. Differentially expressed genes (DEGs) were identified, and Gene Ontology and pathway enrichment analyses were performed. The protein‑protein interaction network was constructed with the Search Tool for the Retrieval of Interacting Genes along with Cytoscape. Receiver operating characteristic curves for predictive power, sensitivity and specificity were constructed. The present study identified specific associated DEGs by using Pearson linear correlation and logistic regression analysis. A mean NLR of 3.96 was determined as the cutoff value in the analysis. In total, 31 genes were initially identified as DEGs associated with elevated NLR. They were mainly enriched in neutrophil activation and neutrophil mediated immunity, in fluid shear stress and atherosclerosis, and transcriptional misregulation in cancer. Three focused DEGs, solute carrier family 22 member 4 (SLC22A4), interleukin‑1 receptor 2 (IL1R2) and vanin 3 (VNN3), were finally revealed to be independently associated with elevated NLR in CHF patients. The present study demonstrated that the three genes SLC22A4, IL1R2 and VNN3 may be independently associated with elevated NLR in CHF patients as potential decisive factors of NLR.

View Figures

View References

1	Tasal A, Erturk M, Uyarel H, Karakurt H, Bacaksiz A, Vatankulu MA, Turfan M, Sonmez O, Erdogan E and Ergelen M: Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure. J Cardiol. 63:418–423. 2014. View Article : Google Scholar : PubMed/NCBI
2	Yan W, Li RJ, Jia Q, Mu Y, Liu CL and He KL: Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure. J Geriatr Cardiol. 14:127–134. 2017.PubMed/NCBI
3	Ostrowska M, Ostrowski A, Łuczak M, Jaguszewski M, Adamski P, Bellwon J, Rynkiewicz A and Gruchała M: Basic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure: Data from a large single-centre cohort. Kardiol Pol. 75:157–163. 2017. View Article : Google Scholar : PubMed/NCBI
4	Ho KK, Anderson KM, Kannel WB, Grossman W and Levy D: Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 88:107–115. 1993. View Article : Google Scholar : PubMed/NCBI
5	Afari ME and Bhat T: Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: An update. Expert Rev Cardiovasc Ther. 14:573–577. 2016. View Article : Google Scholar : PubMed/NCBI
6	Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, Meghani M, Akhtar M and Costantino T: Neutrophil to lymphocyte ratio and cardiovascular diseases: A review. Expert Rev Cardiovasc Ther. 11:55–59. 2013. View Article : Google Scholar : PubMed/NCBI
7	Wasilewski J, Pyka Ł, Hawranek M, Osadnik T, Kurek A, Skrzypek M, Niedziela J, Desperak P, Kułaczkowska Z, Brzezina M, et al: Prognostic value of neutrophil-to-lymphocyte ratio in predicting long-term mortality in patients with ischemic and nonischemic heart failure. Pol Arch Med Wewn. 126:166–173. 2016.PubMed/NCBI
8	Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M and Capodilupo R: Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 107:433–438. 2011. View Article : Google Scholar : PubMed/NCBI
9	Benites-Zapata VA, Hernandez AV, Nagarajan V, Cauthen CA, Starling RC and Tang WH: Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. Am J Cardiol. 115:57–61. 2015. View Article : Google Scholar : PubMed/NCBI
10	Yan W, Liu C, Li R, Mu Y, Jia Q and He K: Usefulness of the neutrophil-to-lymphocyte ratio in predicting adverse events in elderly patients with chronic heart failure. Int Heart J. 57:615–621. 2016. View Article : Google Scholar : PubMed/NCBI
11	Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du P, Wang Q and Yang W: Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies. Cancer Treat Rev. 58:1–13. 2017. View Article : Google Scholar : PubMed/NCBI
12	Shannon CP, Balshaw R, Chen V, Hollander Z, Toma M, McManus BM, Fitzgerald JM, Sin DD, Ng RT and Tebbutt SJ: A novel approach to identifying marker genes and estimating the cellular composition of whole blood from gene expression profiles. bioRxiv. 2:387942016.
13	Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 4:249–264. 2003. View Article : Google Scholar : PubMed/NCBI
14	Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D and Altman RB: Missing value estimation methods for DNA microarrays. Bioinformatics. 17:520–525. 2001. View Article : Google Scholar : PubMed/NCBI
15	Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI
16	Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al: STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43:(Database Issue). D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
17	Gene Ontology Consortium, . The Gene Ontology (GO) project in 2006. Nucleic Acids Res. 34:(Database Issue). D322–D326. 2006. View Article : Google Scholar : PubMed/NCBI
18	Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar : PubMed/NCBI
19	Yu G, Wang LG, Han Y and He QY: clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
20	Budczies J, Klauschen F, Sinn BV, Győrffy B, Schmitt WD, Darb-Esfahani S and Denkert C: Cutoff Finder: A comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One. 7:e518622012. View Article : Google Scholar : PubMed/NCBI
21	Weber C, Zernecke A and Libby P: The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models. Nat Rev Immunol. 8:802–815. 2008. View Article : Google Scholar : PubMed/NCBI
22	Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, Gobunsuy R, Jadonath S, Baldari D, McCord D and Lafferty J: Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 106:470–476. 2010. View Article : Google Scholar : PubMed/NCBI
23	McBride BF, Yang T, Liu K, Urban TJ, Giacomini KM, Kim RB and Roden DM: The organic cation transporter, OCTN1, expressed in the human heart, potentiates antagonism of the HERG potassium channel. J Cardiovasc Pharmacol. 54:63–71. 2009. View Article : Google Scholar : PubMed/NCBI
24	Taubert D, Lazar A, Grimberg G, Jung N, Rubbert A, Delank KS, Perniok A, Erdmann E and Schömig E: Association of rheumatoid arthritis with ergothioneine levels in red blood cells: A case control study. J Rheumatol. 33:2139–2145. 2006.PubMed/NCBI
25	Long F, Wang L, Yang L, Ji Z and Hu Y: Screening hub genes in coronary artery disease based on integrated analysis. Cardiol J. Oct 5–2017.(Epub ahead of print). PubMed/NCBI
26	Stoynev N, Dimova I, Rukova B, Hadjidekova S, Nikolova D, Toncheva D and Tankova T: Gene expression in peripheral blood of patients with hypertension and patients with type 2 diabetes. J Cardiovasc Med (Hagerstown). 15:702–709. 2014. View Article : Google Scholar : PubMed/NCBI
27	Mehra MR, Uber PA and Benitez RM: Gene-based bio-signature patterns and cardiac allograft rejection. Heart Fail Clin. 6:87–92. 2010. View Article : Google Scholar : PubMed/NCBI
28	Chen X, Chen X, Xu Y, Yang W, Wu N, Ye H, Yang JY, Hong Q, Xin Y, Yang MQ, et al: Association of six CpG-SNPs in the inflammation-related genes with coronary heart disease. Hum Genomics. 10 Suppl 2:S212016. View Article : Google Scholar
29	Park HJ, Noh JH, Eun JW, Koh YS, Seo SM, Park WS, Lee JY, Chang K, Seung KB, Kim PJ and Nam SW: Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction. Oncotarget. 6:12970–12983. 2015.PubMed/NCBI
30	Lu Y and Chen X, Yin Z, Zhu S, Wu D and Chen X: Screening for potential serum biomarkers in rat mesangial proliferative nephritis. Proteomics. 16:1015–1022. 2016. View Article : Google Scholar : PubMed/NCBI
31	Jansen PA, Kamsteeg M, Rodijk-Olthuis D, van Vlijmen-Willems IM, de Jongh GJ, Bergers M, Tjabringa GS, Zeeuwen PL and Schalkwijk J: Expression of the vanin gene family in normal and inflamed human skin: Induction by proinflammatory cytokines. J Invest Dermatol. 129:2167–2174. 2009. View Article : Google Scholar : PubMed/NCBI
32	O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Piña IL, Granger CB, Ostergren J, Michelson EL, Solomon SD, Pocock S, et al: Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 115:3111–3120. 2007. View Article : Google Scholar : PubMed/NCBI
33	Cakici M, Cetin M, Doğan A, Oylumlu M, Aktürk E, Polat M, Suner A and Abuş S: Neutrophil to lymphocyte ratio predicts poor functional capacity in patients with heart failure. Turk Kardiyol Dern Ars. 42:612–620. 2014. View Article : Google Scholar : PubMed/NCBI